BBC HomepageWorld ServiceEducation
BBC Homepagelow graphics version | feedback | help
BBC News Online
 You are in: Health
News image
Front Page 
World 
UK 
UK Politics 
Business 
Sci/Tech 
Health 
Background Briefings 
Medical notes 
Education 
Entertainment 
Talking Point 
In Depth 
AudioVideo 
News image
Monday, 29 May, 2000, 01:40 GMT 02:40 UK
Scientists unblock blood vessels
Heart surgery
The condition can require heart surgery
Doctors have developed a life-saving technique that may be able to reverse all types of blood vessel obstruction.

Researchers at The Hospital for Sick Children (HSC) in Toronto, Canada, have successfully treated a condition known as primary pulmonary hypertension in animals.

Pulmonary hypertension is caused by an obstruction of the blood vessels of the lung.



This research may lead to new avenues in the treatment of many cardiovascular conditions

Professor Marlene Rabinovitch, Hospital for Sick Children, Toronto

It is a common complication of most heart and lung diseases, and it leads to heart failure.

Pulmonary hypertension can also occur more rarely as a rapidly progressive and fatal condition that requires long-term intravenous therapy, or a lung or heart-lung transplant.

The HSC doctors treated the condition by blocking the action of an enzyme called elastase.

Researcher Dr Kyle Cowan said: "We were able to completely reverse fatal pulmonary hypertension in an animal model using an elastase inhibitor.

"Not only did it stop the progression of the disease, but the blood vessel reverted to a normal condition."

Elastase causes cells in blood vessels to rapidly divide, so that the vessel becomes obstructed.

The HSC team used a synthetic, chemical compound to induce the cells to die and the excess tissue to be reabsorbed, thus opening up the blood vessel.

New Avenues



We don't know if the same results would be seen in people

British Heart Foundation

Professor Marlene Rabinovitch, who led the HSC team, said: "This research may lead to new avenues in the treatment of many cardiovascular conditions.

"While this study deals with obstructed pulmonary arteries, a similar mechanism may be applicable in reversing coronary disease as well."

Professor Rabinovitch said clinical trials of the drug on humans would be needed before it could be made widely available.

The British Heart Foundation issued a statement which said that sometimes the cause of pulmonary hypertension was unknown, making an effective treatment difficult.

"So far studies on elastase inhibition have only been carried out in a laboratory, so we don't know if the same results would be seen in people.

"Let's hope that this novel approach does bear fruit in future to help some of the people with this debilitating condition."

The research is reported in the June issue of the scientific journal Nature Medicine.

News imageSearch BBC News Online
News image
News image
News imageNews image
Advanced search options
News image
Launch console
News image
News image
News imageBBC RADIO NEWS
News image
News image
News imageBBC ONE TV NEWS
News image
News image
News imageWORLD NEWS SUMMARY
News image
News image
News image
News image
News imageNews imageNews imageNews imagePROGRAMMES GUIDE
Internet links:


The BBC is not responsible for the content of external internet sites

Links to more Health stories are at the foot of the page.


E-mail this story to a friend

Links to more Health stories



News imageNews image